The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I wouldn't buy it, I like p/e ratios too much - but I could see this becoming an intuitive surgical-type stock eventually. It's growing, paying off debt, & this price seems to be a reasonable jumping off point.